This article is intended for primary care physicians, neurologists, and other specialists who care for patients with CDH.
The goal of this activity is to provide the latest medical news to physicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as "financial relationships in any amount, occurring within the past 12 months," that could create a conflict of interest.
Medscape encourages Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape designates this educational activity for
0.25 Category 1 credit(s) toward the AMA Physician's Recognition
Award. Each physician should claim only those credits that reflect the
time he/she actually spent in the activity.
Medscape Medical News (MMN) has been reviewed and is acceptable
for up to 150 Prescribed credits by the American Academy of Family
Physicians. AAFP accreditation begins 09/01/05. Term of approval is for
1 year from this date. This component is approved for 0.25 Prescribed
credit. Credit may be claimed for 1 year from the date of this issue.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 10/24/2005
Valid for credit through: 10/24/2006
processing....
Oct. 24, 2005 — Acupuncture may be helpful for chronic daily headache (CDH), according to the results of a randomized trial published in the October issue of Headache.
"Approximately 4% of adults experience headaches nearly every day," write Remy R. Coeytaux, MD, PhD, from the University of North Carolina at Chapel Hill, and colleagues. "Nonpharmacologic interventions for frequent headaches may be appropriate because medical management alone is often ineffective."
In 74 patients with CDH, the investigators compared medical management provided by neurologists to medical management plus 10 acupuncture treatments. The main endpoints were daily pain severity and headache-related quality of life (QoL).
Patients who received only medical management did not show improvement in any of the standardized measures. Although daily pain severity scores trended downward, they were not different between treatment groups (P = .60). Compared with medical management only, medical management plus acupuncture was associated with an improvement of 3.0 points (95% confidence interval [CI], 1.0 - 4.9) on the Headache Impact Test (HIT) and an increase of at least 8 points on the role limitations caused by physical problems, social functioning, and general mental health domains of the Short Form 36 Health Survey (SF-36). Patients in the acupuncture group were 3.7 times more likely (95% CI, 1.7 - 8.1) to report less pain from headaches at six weeks (absolute risk reduction, 46%; number needed to treat, 2).
"Headache-specialty medical management alone was not associated with improved clinical outcomes among our study population," the authors write. "Supplementing medical management with acupuncture, however, resulted in improvements in health-related QoL and the perception by patients that they suffered less from headaches."
Study limitations include unblinded study design, use of subjective outcomes introducing potential bias, failure to isolate acupuncture as the single causal variable, lack of a sham control, bias inherent in the study design, and inability to evaluate the efficacy of medical care provided by the three study neurologists.
"Additional research is needed to elucidate the extent to which placebo effects associated with acupuncture contribute to clinical benefit, to identify clinical characteristics that predict favorable response to acupuncture, to explore which acupuncture traditions and protocols are most effective for treating the various causes and manifestations of CDH, and to determine whether acupuncture is a cost-effective approach to the treatment of frequent headaches," the authors write.
The National Institutes of Health have disclosed that they funded this study, and the Verne S. Caviness General Clinical Research Center at University of North Carolina School of Medicine also disclosed that they supported it. The Robert Wood Johnson Clinical Scholars Program have disclosed that they supported Dr. Coeytaux during the design phase of the study.
Headache. 2005;45:1113-1123
CDH is a clinical syndrome characterized by the occurrence of headache 15 or more days per month. According to the current authors, it affects 3% to 5% of the general population and is responsible for up to 80% of new presentations to headache specialty clinics. Headache type may consist of migraine, tension, or other headaches by the International Headache Society classification system. Medications commonly used for this condition include acetaminophen, aspirin, nonsteroidal anti-inflammatory drugs, triptans, narcotics, and barbiturates, but all are associated with adverse effects and may paradoxically convert episodic to chronic headaches. Acupuncture has been described as a promising treatment of CDH, and according to the current authors, a systematic review identified 23 studies in which acupuncture was considered positive for various types of headache.
This is a randomized, open clinical trial conducted on patients with CDH at a neurology clinic to examine the effect of adjunctive acupuncture on CDH outcomes for six weeks.